Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study

被引:0
作者
Ulrik M. Mogensen
Charlotte Andersson
Emil L. Fosbøl
Tina K. Schramm
Allan Vaag
Nikolai M. Scheller
Christian Torp-Pedersen
Gunnar Gislason
Lars Køber
机构
[1] University Hospital Rigshospitalet,The Heart Centre, Department of Cardiology
[2] University Hospital Gentofte,Department of Cardiology
[3] University Hospital Frederiksberg,Department of Cardiology
[4] University Hospital Rigshospitalet,Department of Endocrinology
[5] Aalborg University,Department of Health Science and Technology
[6] University of Southern Denmark,National Institute of Public Health
[7] University of Copenhagen,Faculty of Health and Medical Sciences
来源
Diabetologia | 2015年 / 58卷
关键词
Cardiovascular disease; Mortality; Risk; Treatment; Type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:50 / 58
页数:8
相关论文
共 113 条
[1]  
Turner RC(1999)Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group JAMA 281 2005-2012
[2]  
Cull CA(2009)Medical management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetologia 52 17-30
[3]  
Frighi V(2012)Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 55 1577-1596
[4]  
Holman RR(2002)Clinical practice. Initial management of glycemia in type 2 diabetes mellitus N Engl J Med 347 1342-1349
[5]  
Nathan DM(2002)Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57) Diabetes Care 25 330-336
[6]  
Buse JB(1992)Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis Diabetes Care 15 953-959
[7]  
Davidson MB(2003)Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 383-393
[8]  
Inzucchi SE(1990)Combination insulin-sulfonylurea therapy Diabetes Care 13 667-675
[9]  
Bergenstal RM(2008)Intensive glycemic control in the ACCORD and ADVANCE trials N Engl J Med 358 2630-2633
[10]  
Buse JB(2009)Glibenclamide-related excess in total and cardiovascular mortality risks: data from large Ukrainian observational cohort study Diabetes Res Clin Pract 86 247-253